1. Vila J, Sáez-López E, Johnson JR, Römling U, Dobrindt U, Cantón R, et al. Escherichia coli: an old friend with new tidings. FEMS Microbiol Rev. 2016; 40(4): 437-63. [
DOI:10.1093/femsre/fuw005]
2. Pitout JDD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015; 59(10): 5873-84. [
DOI:10.1128/AAC.01019-15]
3. Kaper JB, Nataro JP, Mobley HL. Pathogenic escherichia coli. Nature Rev Microbiol. 2004; 2(2): 123-40. [
DOI:10.1038/nrmicro818]
4. Aye SM, Galani I, Yu H, Wang J, Chen K, Wickremasinghe H, et al. Polymyxin triple combinations against polymyxin-resistant, multidrug-resistant, KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2020; 64(8): e00246-20. [
DOI:10.1128/AAC.00246-20]
5. Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens. 2014; 3(3): 743-58. [
DOI:10.3390/pathogens3030743]
6. Matuschek E, Åhman J, Webster C, Kahlmeter G. Antimicrobial susceptibility testing of colistin-evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clin Microbiol Infect. 2018; 24(8): 865-70. [
DOI:10.1016/j.cmi.2017.11.020]
7. Parte A, Whitman WB, Goodfellow M, Kämpfer P, Busse H-J, Trujillo ME, et al. Bergey's manual of systematic bacteriology: volume 5: the Actinobacteria: Springer Science & Business Media; 2012.
8. Osman EA, El-Amin N, Adrees EA, Al-Hassan L, Mukhtar M. Comparing conventional, biochemical and genotypic methods for accurate identification of Klebsiella pneumoniae in Sudan. Access Microbiol. 2020; 2(3). [
DOI:10.1099/acmi.0.000096]
9. He Y, Guo X, Xiang S, Li J, Li X, Xiang H, et al. Comparative analyses of phenotypic methods and 16S rRNA, khe, rpoB genes sequencing for identification of clinical isolates of Klebsiella pneumoniae. Antonie Van Leeuwenhoek. 2016; 109(7): 1029-40. [
DOI:10.1007/s10482-016-0702-9]
10. Dasen G, Smutny J, Teuber M, Meile L. Classification and identification of propionibacteria based on ribosomal RNA genes and PCR. System Apply Microbiol. 1998; 21(2): 251-9. [
DOI:10.1016/S0723-2020(98)80030-1]
11. https://clsi.org/media/pjfbviql/m100ed34e_sample.pdf. CLSI M100.
12. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas M, Giske C, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012; 18(3): 268-81. [
DOI:10.1111/j.1469-0691.2011.03570.x]
13. Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended‐spectrum β‐lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2008; 14: 90-103. [
DOI:10.1111/j.1469-0691.2007.01846.x]
14. Yousefi Mashouf R, Alijani P, Saidijam M, Alikhani MY, Rashidi H. Study of antibiotic resistance pattern and phenotypic detection of ESBLs in Klebsiella pneumoniae strains isolated from clinical samples and determination of minimum inhibitory concentrations of imipenem and ceftazidim antibiotics. Avicenna J Clin Med. 2014; 20(4): 295-302.
15. Burton E, Yakandawala N, LoVetri K, Madhyastha M. A microplate spectrofluorometric assay for bacterial biofilms. J Indust Microbiol Biotechnol. 2007; 34(1): 1-4. [
DOI:10.1007/s10295-006-0086-3]
16. Stepanović S, Vuković D, Dakić I, Savić B, Švabić-Vlahović M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Method. 2000; 40(2): 175-9. [
DOI:10.1016/S0167-7012(00)00122-6]
17. Mostafavi SN, Rostami S, Nejad YR, Ataei B, Mobasherizadeh S, Cheraghi A, et al. Antimicrobial resistance in hospitalized patients with community acquired urinary tract infection in Isfahan, Iran. Arch Iran Med. 2021; 24(3): 187-92. [
DOI:10.34172/aim.2021.29]
18. Tanhaei S, Mahmoudi S, Pournajafi A, Mahmoudi A. Investigating the antibiotic resistance pattern of extended spectrum beta lactamase producing Klebsiella pneumoniae isolates from urinary tract infections in Zanjan city, Iran. Int J Biol Genetic. 2020.
19. Vaez H, Sahebkar A, Khademi F. Carbapenem-Resistant Klebsiella pneumoniae in Iran: a systematic review and meta-analysis. J Chemother. 2019; 31(1): 1-8. [
DOI:10.1080/1120009X.2018.1533266]
20. Lopes E, Saavedra MJ, Costa E, de Lencastre H, Poirel L, Aires-de-Sousa M. Epidemiology of carbapenemase-producing Klebsiella pneumoniae in northern Portugal: Predominance of KPC-2 and OXA-48. J Glob Antimicrob Resist. 2020; 22: 349-53. [
DOI:10.1016/j.jgar.2020.04.007]
21. Shadkam S, Goli HR, Mirzaei B, Gholami M, Ahanjan M. Correlation between antimicrobial resistance and biofilm formation capability among Klebsiella pneumoniae strains isolated from hospitalized patients in Iran. Ann Clin Microbiol Antimicrob. 2021; 20: 1-7. [
DOI:10.1186/s12941-021-00418-x]
22. Mirzaei B, Babaei R, Bazgir ZN, Goli HR, Keshavarzi S, Amiri E. Prevalence of Enterobacteriaceae spp. and its multidrug-resistant rates in clinical isolates: a two-center cross-sectional study. Molec Biol Report. 2021; 48: 665-75. [
DOI:10.1007/s11033-020-06114-x]